Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Codeine	O
/	O
Percocet	O
/	O
Demerol	O
/	O
Pneumovax	O
23	O
/	O
adhesive	O
tape	O
/	O
flouridated	O
toothpaste	O
/	O
clopidogrel	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Syncope	O
and	O
fall	B-Falls
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
an	O
___	O
female	O
history	O
of	O
severe	O
aortic	O
stenosis,	O
atrial	O
fibrillation,	O
three	O
vessel	O
CAD	O
with	O
recent	O
PCI	O
to	O
RCA	O
on	O
triple	O
therapy,	O
and	O
HTN	O
presenting	O
status	O
post	O
syncope	O
and	O
fall.	B-Falls
The	O
patient	O
was	O
at	O
rehabilitation	O
after	O
recent	O
TAVR,	O
discharged	O
from	O
___	O
on	O
___.	O
Went	O
to	O
restroom	O
on	O
night	O
prior	O
to	O
admission	O
and	O
syncopized	O
while	O
walking.	O
She	O
denied	O
chest	O
pain,	O
palpitations,	O
dyspnea	O
prior	O
to	O
the	O
event.	O
She	O
woke	O
up	O
on	O
the	O
floor	O
and	O
had	O
right	O
hip	O
pain.	O
She	O
denied	O
headache,	O
vision	O
change,	O
or	O
nausea/vomiting.	O
She	O
was	O
initially	O
asymptomatic	O
besides	O
hip	O
pain.	O
Of	O
note,	O
her	O
Lasix	O
was	O
increased	O
to	O
60	O
mg	O
daily	O
on	O
___	O
because	O
of	O
weight	O
gain	O
of	O
7	O
lbs	O
in	O
1	O
week	O
(baseline	O
143-144	O
lbs)	O
and	O
continued	O
on	O
metolazone.	O
She	O
was	O
due	O
to	O
get	O
repeat	O
lytes	O
on	O
___.	O
In	O
the	O
ED	O
initial	O
vitals	O
were:	O
T	O
98.8	O
HR	O
70	O
BP	O
129/30	O
RR	O
16	O
Pox	O
100%	O
on	O
RA.	O
EKG:	O
Sinus	O
rhythm	O
with	O
prolonged	O
PR	O
interval	O
(257).	O
No	O
ST	O
changes,	O
TWI,	O
or	O
new	O
bundle	O
branch	O
blocks	O
noted.	O
Labs	O
notable	O
for:	O
Hb	O
7.5	O
(baseline	O
9.5-10.5),	O
Na	O
132,	O
Cr	O
1.3,(baseline	O
1.1-1.3),	O
troponin	O
0.06,	O
proBNP	O
___,	O
INR	O
2.3.	O
Imaging	O
studies	O
including	O
___,	O
CT	O
spine,	O
and	O
R	O
hip	O
x-ray	O
were	O
negative.	O
On	O
the	O
floor	O
the	O
patient	O
was	O
tearful	O
and	O
reported	O
that	O
she	O
was	O
cold.	O
She	O
was	O
disappointed	O
by	O
what	O
she	O
saw	O
as	O
a	O
setback	O
to	O
her	O
rehab.	O
She	O
had	O
pain	O
in	O
both	O
of	O
her	O
hips,	O
and	O
a	O
cough.	O
She	O
reported	O
she	O
hasn't	O
had	O
much	O
of	O
an	O
appetite	O
at	O
rehab	O
and	O
has	O
been	O
eating	O
<50%	O
of	O
her	O
meals.	O
Past	O
Medical	O
History:	O
PMH:	O
AS	O
(Ao	O
-	O
0.9cm/s2)	O
AF	O
(on	O
coumadin)	O
HTN	O
(L	O
renal	O
artery	O
stenosis)	O
Breast	O
CA	O
(s/p	O
R	O
mastectomy	O
___	O
Gait	O
disorder	O
Gout	O
OA	O
sleep	O
disorder,	O
peripheral	O
neuropathy,	O
heart	O
murmur,	O
exertional	O
dyspnea	O
PSH:	O
R	O
partial	O
mastectomy	O
(___),	O
bilateral	O
TKR,	O
back	O
fusion,	O
multiple	O
orthopedic	O
procedures	O
Social	O
History:	O
___	O
Family	O
History:	O
maternal	O
aunt	O
with	O
breast	O
cancer	O
in	O
her	O
___	O
uncle	O
who	O
had	O
leukemia,	O
a	O
maternal	O
uncle	O
with	O
pancreatic	O
cancer,	O
a	O
maternal	O
aunt	O
with	O
bladder	O
cancer	O
and	O
a	O
niece	O
at	O
age	O
___	O
with	O
malignant	O
melanoma	O
who	O
died	O
at	O
age	O
___.	O
Ms.	O
___	O
is	O
of	O
___	O
descent.In	O
___,	O
she	O
underwent	O
genetic	O
BRCA1	O
and	O
2	O
testing	O
for	O
the	O
three-site	O
founder	O
mutations	O
and	O
was	O
negative.	O
Father	O
died	O
at	O
age	O
___	O
of	O
an	O
MI.	O
Mother	O
passed	O
away	O
in	O
her	O
___,	O
had	O
HTN.	O
One	O
sister	O
age	O
___,	O
who	O
has	O
atherosclerosis	O
and	O
claudication,	O
CKD.	O
Had	O
3	O
children,	O
one	O
passed	O
away	O
of	O
non-medical	O
disease.	O
No	O
other	O
medical	O
problems	O
in	O
other	O
children.	O
Physical	O
Exam:	O
PHYSICAL	O
EXAM	O
ON	O
ADMISSION:	O
VS:	O
T	O
98.7	O
F	O
BP	O
180/62	O
HR	O
___	O
RR	O
20	O
O2	O
SAT	O
99%	O
RA	O
GENERAL:	O
Alert,	O
oriented,	B-Delirium
tearful	O
HEENT:	O
Normocephalic	O
atraumatic	O
with	O
no	O
tenderness	O
to	O
palpation.	O
Sclera	O
anicteric.	O
PERRL.	O
EOMI.	O
Conjunctiva	O
were	O
pink.	O
No	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
NECK:	O
Supple.	O
JVP	O
not	O
elevated	O
CARDIAC:	O
Prominent	O
systolic	O
murmur,	O
regular	O
rate	O
LUNGS:	O
mild	O
crackles,	O
expiratory	O
rhonchi	O
bilaterally	O
ABDOMEN:	O
Soft,	O
non-tender,	O
non-distended.	O
No	O
hepatomegaly.	O
No	O
splenomegaly.	O
EXTREMITIES:	O
Warm,	O
well	O
perfused	O
with	O
scattered	O
ecchymoses.	O
Trace	O
peripheral	O
edema.	O
Large	O
purple	O
ecchymosis	O
on	O
the	O
interior	O
right	O
thigh,	O
tender	O
to	O
palpation.	O
SKIN:	O
No	O
significant	O
skin	O
lesions	O
or	O
rashes.	O
PULSES:	O
Distal	O
pulses	O
palpable	O
and	O
symmetric.	O
PHYSICAL	O
EXAM	O
ON	O
DISCHARGE:	O
VS:	O
T	O
98.7,	O
BP	O
97-141/33-47,	O
HR	O
66-77,	O
RR	O
___,	O
O2	O
SAT	O
95-96%	O
RA	O
Weight:	O
67.2kg	O
I/O	O
___	O
GENERAL:	O
Alert,	O
oriented,	B-Delirium
laying	O
in	O
bed	O
NECK:	O
Supple.	O
JVP	O
not	O
elevated	O
CARDIAC:	O
Prominent	O
systolic	O
murmur,	O
regular	O
rate,	O
no	O
rubs	O
or	O
gallops	O
LUNGS:	O
CTAB,	O
no	O
wheezing/crackles/rhonchi	O
ABDOMEN:	O
Soft,	O
non-tender,	O
non-distended.	O
No	O
hepatomegaly.	O
No	O
splenomegaly.	O
EXTREMITIES:	O
Large	O
resolving	O
purple	O
ecchymosis	O
on	O
the	O
interior	O
right	O
thigh,	O
tender	O
to	O
palpation.	O
Pertinent	O
Results:	O
LABS	O
ON	O
ADMISSION:	O
___	O
11:50AM	O
BLOOD	O
WBC-8.6	O
RBC-2.26*	O
Hgb-7.5*	O
Hct-23.5*	O
MCV-104*	O
MCH-33.2*	O
MCHC-31.9*	O
RDW-16.3*	O
RDWSD-62.0*	O
Plt	O
___	O
___	O
11:50AM	O
BLOOD	O
___	O
PTT-37.4*	O
___	O
___	O
11:50AM	O
BLOOD	O
Glucose-122*	O
UreaN-41*	O
Creat-1.3*	O
Na-132*	O
K-3.8	O
Cl-93*	O
HCO3-26	O
AnGap-17	O
___	O
11:50AM	O
BLOOD	O
proBNP-2125*	O
___	O
11:50AM	O
BLOOD	O
cTropnT-0.06*	O
___	O
11:50AM	O
BLOOD	O
Iron-26*	O
___	O
11:50AM	O
BLOOD	O
calTIBC-216*	O
VitB12-1364*	O
Folate->20	O
___	O
Ferritn-296*	O
TRF-166*	O
___	O
12:35PM	O
URINE	O
Blood-NEG	O
Nitrite-NEG	O
Protein-NEG	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-7.0	O
Leuks-TR	O
___	O
01:11PM	O
URINE	O
RBC-<1	O
WBC-2	O
Bacteri-FEW	O
Yeast-NONE	O
Epi-2	O
LABS	O
AT	O
DISCHARGE:	O
___	O
07:19AM	O
BLOOD	O
WBC-8.5	O
RBC-2.82*	O
Hgb-8.8*	O
Hct-27.1*	O
MCV-96	O
MCH-31.2	O
MCHC-32.5	O
RDW-19.3*	O
RDWSD-67.7*	O
Plt	O
___	O
___	O
07:19AM	O
BLOOD	O
___	O
PTT-44.0*	O
___	O
___	O
07:19AM	O
BLOOD	O
Glucose-94	O
UreaN-44*	O
Creat-1.3*	O
Na-133	O
K-3.9	O
Cl-96	O
HCO3-22	O
AnGap-19	O
___	O
07:19AM	O
BLOOD	O
Calcium-8.4	O
Phos-3.5	O
Mg-2.5	O
MICROBIOLOGY:	O
URINE	O
CULTURE	O
(Final	O
___:	O
MIXED	O
BACTERIAL	O
FLORA	O
(	O
>=	O
3	O
COLONY	O
TYPES),	O
CONSISTENT	O
WITH	O
SKIN	O
AND/OR	O
GENITAL	O
CONTAMINATION.	O
IMAGING	O
STUDIES/PROCEDURES:	O
CT	O
SPINE	B-Vertebral_compression_fracture
WITHOUT	O
CONTRAST	O
(___):	O
FINDINGS:	O
Alignment	O
is	O
maintained.	O
No	O
acute	O
fractures	B-Vertebral_compression_fracture
are	O
identified.	O
There	O
are	O
mild	O
multilevel	O
degenerative	O
changes,	O
resulting	O
in	O
mild	O
bilateral	O
neural	O
foraminal	O
narrowing	O
at	O
C5-C6.	O
There	O
is	O
no	O
significant	O
canal	O
narrowing.	O
There	O
is	O
minimal	O
anterolisthesis	O
of	O
C7	O
on	O
T1.	O
There	O
is	O
no	O
prevertebral	O
edema.	O
There	O
are	O
carotid	O
artery	O
calcifications.	O
The	O
thyroid	O
is	O
unremarkable.	O
There	O
is	O
scarring	O
at	O
the	O
lung	O
apices,	O
and	O
possible	O
mild	O
interstitial	O
edema.	O
IMPRESSION:	O
1.	O
No	O
acute	O
fracture	O
or	O
traumatic	O
dislocation.	O
2.	O
Mild	O
multilevel	O
degenerative	O
changes.	O
3.	O
Possible	O
mild	O
interstitial	O
edema	O
at	O
the	O
lung	O
apices.	O
Please	O
see	O
chest	O
radiograph	O
performed	O
on	O
same	O
day	O
for	O
further	O
evaluation.	O
HIP	B-Hip_fracture
(UNILAT	O
2	O
VIEW)	O
W/PELVIS	O
(1	O
VIEW)	O
RIGHT	O
(___):	O
FINDINGS:	O
Patient	O
is	O
status	O
post	O
left	O
hip	O
arthroplasty	O
with	O
prosthesis	O
in	O
anatomic	O
alignment.	O
Severe	O
degenerative	O
changes	O
of	O
the	O
right	O
hip	O
are	O
re-	O
demonstrated.	O
No	O
acute	O
fracture	B-Hip_fracture
or	O
dislocation	O
is	O
seen.	O
Degenerative	O
change	O
at	O
the	O
pubic	O
symphysis	O
are	O
again	O
noted.	O
Postsurgical	O
changes	O
including	O
spinal	O
hardware	O
and	O
bone	O
graft	O
are	O
seen	O
in	O
the	O
partially	O
imaged	O
lower	B-Vertebral_compression_fracture
lumbar	B-Vertebral_compression_fracture
spine.	B-Vertebral_compression_fracture
IMPRESSION:	O
No	O
acute	O
fracture.	B-Vertebral_compression_fracture
Status	O
post	O
left	O
hip	O
arthroplasty	O
with	O
prosthesis	O
in	O
anatomic	O
alignment	O
without	O
evidence	O
of	O
hardware	O
complication.	O
Degenerative	O
changes	O
as	O
above.	O
CXR	O
(___):	O
FINDINGS:	O
Patient	O
is	O
status	O
post	O
TAVR.	O
Since	O
the	O
prior	O
study,	O
there	O
is	O
interval	O
increase	O
in	O
pulmonary	O
vascular	O
markings	O
suggesting	O
vascular	O
congestion/minimal	O
interstitial	O
edema,	O
superimposed	O
on	O
chronic	O
lung	O
disease.	O
Mild	O
basilar	O
atelectasis	O
is	O
seen	O
without	O
definite	O
focal	O
consolidation.	O
No	O
large	O
pleural	O
effusion	O
or	O
pneumothorax.	O
The	O
cardiac	O
silhouette	O
is	O
mildly	O
enlarged.	O
The	O
aorta	O
is	O
calcified	O
and	O
tortuous.	O
IMPRESSION:	O
Since	O
the	O
prior	O
study,	O
there	O
is	O
interval	O
increase	O
in	O
pulmonary	O
vascular	O
markings	O
suggesting	O
vascular	O
congestion/minimal	O
interstitial	O
edema,	O
superimposed	O
on	O
chronic	O
lung	O
disease.	O
Mild	O
basilar	O
atelectasis	O
is	O
seen	O
without	O
definite	O
focal	O
consolidation	O
CT	O
ABDOMEN/PELVIS	O
WITHOUT	O
CONTRAST	O
(___):	O
FINDINGS:	O
LOWER	O
CHEST:	O
Since	O
the	O
prior	O
CT	O
scan	O
of	O
the	O
chest,	O
there	O
has	O
been	O
interval	O
increase	O
in	O
the	O
bilateral	O
diffuse	O
but	O
predominantly	O
peripheral	O
ground-glass	O
opacities	O
with	O
inter	O
and	O
intralobular	O
septal	O
thickening.	O
There	O
is	O
a	O
trace	O
left	O
pleural	O
effusion.	O
Coronary	O
artery	O
calcifications	O
noted.	O
Mild	O
cardiomegaly	O
with	O
evidence	O
of	O
prior	O
aortic	O
valve	O
replacement.	O
Coronary	O
arterial	O
calcification	O
is	O
present.	O
ABDOMEN:	O
HEPATOBILIARY:	O
The	O
liver	O
demonstrates	O
homogeneous	O
attenuation	O
throughout.	O
There	O
is	O
no	O
evidence	O
of	O
focal	O
lesions	O
within	O
the	O
limitations	O
of	O
an	O
unenhanced	O
scan.	O
There	O
is	O
no	O
evidence	O
of	O
intrahepatic	O
or	O
extrahepatic	O
biliary	O
dilatation.	O
The	O
gallbladder	O
is	O
within	O
normal	O
limits.	O
PANCREAS:	O
The	O
pancreas	O
has	O
normal	O
attenuation	O
throughout,	O
without	O
evidence	O
of	O
focal	O
lesions	O
within	O
the	O
limitations	O
of	O
an	O
unenhanced	O
scan.	O
There	O
is	O
no	O
pancreatic	O
ductal	O
dilatation.	O
There	O
is	O
no	O
peripancreatic	O
stranding.	O
SPLEEN:	O
The	O
spleen	O
shows	O
normal	O
size	O
and	O
attenuation	O
throughout,	O
without	O
evidence	O
of	O
focal	O
lesions.	O
ADRENALS:	O
The	O
right	O
and	O
left	O
adrenal	O
glands	O
are	O
normal	O
in	O
size	O
and	O
shape.	O
URINARY:	O
The	O
kidneys	O
are	O
normal	O
and	O
symmetric	O
in	O
size.	O
Incidental	O
note	O
is	O
made	O
of	O
a	O
duplicated	O
right	O
collecting	O
system.	O
There	O
is	O
no	O
evidence	O
of	O
focal	O
renal	O
lesions	O
within	O
the	O
limitations	O
of	O
an	O
unenhanced	O
scan.	O
Several	O
punctate	O
calcification	O
in	O
the	O
left	O
kidney,	O
likely	O
parenchymal	O
in	O
location.	O
There	O
is	O
no	O
hydronephrosis	O
or	O
nephrolithiasis.	O
There	O
is	O
no	O
perinephric	O
abnormality.	O
GASTROINTESTINAL:	O
Small	O
hiatal	O
hernia.	O
Hyperdense	O
ingested	O
material	O
is	O
present	O
at	O
the	O
pylorus.	O
Small	O
bowel	O
loops	O
demonstrate	O
normal	O
caliber	O
and	O
wall	O
thickness	O
throughout.	O
A	O
duodenal	O
diverticulum	O
is	O
again	O
noted.	O
Mild	O
circumferential	O
wall	O
thickening	O
of	O
the	O
rectum	O
may	O
be	O
secondary	O
to	O
underdistention.	O
Otherwise	O
the	O
rectum	O
and	O
colon	O
are	O
within	O
normal	O
limits.	O
The	O
appendix	O
is	O
not	O
visualized.	O
PELVIS:	O
The	O
urinary	O
bladder	O
and	O
distal	O
ureters	O
are	O
grossly	O
unremarkable,	O
although	O
there	O
is	O
marked	O
streak	O
artifact	O
from	O
the	O
total	O
left	O
hip	O
arthroplasty.	O
There	O
is	O
no	O
free	O
fluid	O
in	O
the	O
pelvis.	O
No	O
evidence	O
of	O
retroperitoneal	O
or	O
intramuscular	O
hematoma.	O
LYMPH	O
NODES:	O
There	O
is	O
no	O
retroperitoneal	O
or	O
mesenteric	O
lymphadenopathy.	O
There	O
is	O
no	O
pelvic	O
or	O
inguinal	O
lymphadenopathy.	O
VASCULAR:	O
There	O
is	O
no	O
abdominal	O
aortic	O
aneurysm.	O
Marked	O
atherosclerotic	O
disease	O
is	O
noted.	O
BONES:	O
There	O
is	O
no	O
evidence	O
of	O
worrisome	O
osseous	O
lesions	O
or	O
acute	O
fracture.	B-Hip_fracture
The	O
patient	O
is	O
status	O
post	O
total	O
left	O
hip	B-Hip_fracture
arthroplasty	O
and	O
posterior	O
spinal	O
fusion	O
and	O
laminectomies	O
at	O
L3	O
through	O
L5.	O
Unchanged	O
grade	O
1	O
anterolisthesis	O
of	O
L4	O
on	O
L5.	O
There	O
are	O
moderate	O
degenerative	O
changes	O
of	O
right	O
hip	O
joint.	O
SOFT	O
TISSUES:	O
Small	O
fat	O
containing	O
umbilical	O
hernia.	O
Nonspecific	O
subcutaneous	O
fat	O
stranding	O
in	O
the	O
anteromedial	O
soft	O
tissues	O
of	O
the	O
right	O
upper	O
thigh	O
without	O
associated	O
skin	O
thickening	O
or	O
subcutaneous	O
collection.	O
No	O
hematoma	O
seen	O
in	O
the	O
upper	O
thigh.	O
IMPRESSION:	O
1.	O
No	O
evidence	O
of	O
retroperitoneal	O
or	O
intramuscular	O
bleed.	O
2.	O
No	O
acute	O
abdominopelvic	O
abnormality.	O
3.	O
Interval	O
increase	O
in	O
the	O
bilateral	O
diffuse	O
ground-glass	O
opacities	O
and	O
interstitial	O
markings	O
likely	O
reflecting	O
a	O
combination	O
of	O
pulmonary	O
edema	O
on	O
a	O
background	O
of	O
chronic	O
interstitial	O
lung	O
disease.	O
ECHO	O
(___):	O
This	O
study	O
was	O
compared	O
to	O
the	O
prior	O
study	O
of	O
___.	O
LEFT	O
ATRIUM:	O
Elongated	O
LA.	O
RIGHT	O
ATRIUM/INTERATRIAL	O
SEPTUM:	O
Mildly	O
dilated	O
RA.	O
LEFT	O
VENTRICLE:	O
Mild	O
symmetric	O
LVH	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
(LVEF>55%).	O
False	O
LV	O
tendon	O
(normal	O
variant).	O
TDI	O
E/e'	O
>13,	O
suggesting	O
PCWP>18mmHg.	O
No	O
resting	O
LVOT	O
gradient.	O
RIGHT	O
VENTRICLE:	O
Normal	O
RV	O
chamber	O
size	O
and	O
free	O
wall	O
motion.	O
AORTIC	O
VALVE:	O
Evolut	O
biologic	O
AVR.	O
AVR	O
well	O
seated,	O
normal	O
leaflet/disc	O
motion	O
and	O
transvalvular	O
gradients.	O
Paravalvular	O
leak	O
present.	O
MITRAL	O
VALVE:	O
Moderately	O
thickened	O
mitral	O
valve	O
leaflets.	O
No	O
MVP.	O
Mild	O
mitral	O
annular	O
calcification.	O
Eccentric	O
MR	O
___.	O
Mild	O
(1+)	O
MR.	O
[Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
MR	O
may	O
be	O
significantly	O
UNDERestimated.]	O
TRICUSPID	O
VALVE:	O
Normal	O
tricuspid	O
valve	O
leaflets.	O
Mild	O
to	O
moderate	O
[___]	O
TR.	O
Moderate	O
PA	O
systolic	O
hypertension.	O
PULMONIC	O
VALVE/PULMONARY	O
ARTERY:	O
Normal	O
pulmonic	O
valve	O
leaflet.	O
No	O
PS.	O
Physiologic	O
PR.	O
PERICARDIUM:	O
No	O
pericardial	O
effusion.	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
atrial	O
fibrillation,	O
aortic	O
stenosis	O
s/p	O
recent	O
TAVR,	O
CAD	O
s/p	O
DES	O
currently	O
on	O
plavix,	O
who	O
presented	O
from	O
rehab	O
with	O
syncope	O
of	O
unclear	O
origin.	O
#Syncope	O
-	O
various	O
causes	O
were	O
considered	O
for	O
the	O
patient's	O
syncope/fall	I-Falls
including	O
cardiogenic	O
causes,	O
neurogenic	O
causes,	O
overdiuresis,	O
poor	O
PO	O
intake,	O
vagal	O
episode,	O
and/or	O
anemia.	O
An	O
EP	O
consult	O
was	O
obtained	O
for	O
advice	O
regarding	O
evaluation	O
and	O
management	O
of	O
syncope	O
in	O
the	O
setting	O
of	O
presumed	O
AV	O
nodal	O
disease	O
and	O
a	O
recent	O
TAVR.	O
It	O
was	O
noted	O
that,	O
on	O
her	O
EKG,	O
the	O
patient	O
has	O
noticeable	O
shortening	O
of	O
her	O
PR	O
interval	O
compared	O
to	O
post-TAVR.	O
She	O
has	O
had	O
no	O
evidence	O
of	O
second	O
degree	O
AV	O
block	O
on	O
telemetry.	O
Her	O
bradycardic	O
episode	O
captured	O
on	O
tele	O
showed	O
sinus	O
bradycardia	O
with	O
junctional	O
escape.	O
The	O
patient	O
denied	O
any	O
concerning	O
symptoms	O
to	O
suggest	O
that	O
she	O
has	O
been	O
having	O
intermittent	O
arrhythmia	O
during	O
the	O
last	O
several	O
weeks.	O
Additionally,	O
conduction	O
disease	O
related	O
to	O
TAVR	O
is	O
most	O
common	O
immediately	O
post-op	O
and	O
becomes	O
more	O
rare	O
as	O
time	O
passes	O
from	O
the	O
initial	O
placement	O
of	O
the	O
valve.	O
An	O
ECHO	O
was	O
additionally	O
obtained	O
which	O
revealed	O
a	O
well	O
seated	O
Evolute	O
aortic	O
bioprosthesis	O
with	O
normal	O
gradients	O
and	O
no	O
rest/valsalva	O
LVOT	O
obstruction.	O
Mild	O
to	O
moderate	O
paravalvular	O
leak.	O
Moderate	O
pulmonary	O
hypertension.	O
Increased	O
PCWP.	O
Syncope	O
thought	O
to	O
be	O
likely	O
multifactorial	O
in	O
nature,	O
including	O
low	O
BP/HR	O
upon	O
wakening	O
in	O
early	O
morning,	O
increased	O
vagal	O
tone,	O
and	O
overdiuresis	O
with	O
Lasix.	O
EP	O
recommended	O
having	O
an	O
event	O
monitor	O
at	O
some	O
point	O
to	O
capture	O
recurrent	O
syncopal	O
episodes.	O
#Macrocytic	O
anemia:	O
Patient	O
responded	O
well	O
to	O
2	O
units	O
of	O
pRBCs	O
given	O
on	O
day	O
of	O
admission	O
(HGB	O
7.5	O
on	O
day	O
of	O
admission).	O
CT	O
abdomen	O
and	O
pelvis	O
showed	O
no	O
e/o	O
retroperitoneal	O
or	O
intramuscular	O
bleed.	O
Iron	O
at	O
26,	O
TIBC	O
at	O
216,	O
and	O
ferritin	O
at	O
296	O
which	O
may	O
indicate	O
a	O
component	O
of	O
anemia	O
of	O
chronic	O
disease.	O
Stool	O
guaiac	O
negative.	O
Haptoglobin	O
WNL.	O
Patient	O
remains	O
asymptomatic	O
without	O
c/f	O
active	O
bleeding.	O
Patient's	O
last	O
Hg	O
level	O
was	O
stable	O
at	O
8.8	O
on	O
day	O
of	O
discharge.	O
No	O
e/o	O
B12	O
or	O
folate	O
deficiency.	O
#	O
CKD:	O
creatinine	O
mildly	O
elevated	O
at	O
1.4	O
from	O
1.2	O
at	O
time	O
of	O
discharge	O
a	O
couple	O
of	O
weeks	O
ago.	O
Thought	O
to	O
be	O
likely	O
___	O
poor	O
PO	O
intake.	O
Patient	O
was	O
not	O
given	O
IVF	O
fluids	O
during	O
admission	O
as	O
Lasix	O
was	O
held	O
i/s/o	O
possible	O
overdiuresis	O
with	O
recent	O
episode	O
of	O
syncope	O
and	O
as	O
patient	O
had	O
already	O
received	O
2	O
units	O
of	O
pRBCs	O
during	O
her	O
admission.	O
#Atrial	O
fibrillation:	O
Continued	O
home	O
warfarin	O
dosing.	O
INR	O
2.3	O
on	O
admission	O
and	O
increased	O
on	O
home	O
regimen	O
to	O
3.7	O
on	O
discharge.	O
Unclear	O
cause	O
of	O
acute	O
increase	O
as	O
there	O
were	O
no	O
change	O
in	O
meds.	O
Possibly	O
due	O
to	O
poor	O
PO	O
intake.	O
#CAD:	O
s/p	O
stenting	O
in	O
___.	O
Continued	O
ASA	O
81,	O
Plavix	O
75,	O
atorvastatin	O
80.	O
MetoprololXL	O
50mg	O
was	O
decreased	O
to	O
25mg	O
for	O
HR	O
in	O
the	O
55-65	O
range	O
CHRONIC	O
ISSUES:	O
===============	O
#Restless	O
leg:	O
patient	O
was	O
continued	O
on	O
her	O
home	O
pramipexole	O
#Hypothyroidism:	O
patient	O
was	O
continued	O
on	O
her	O
home	O
Levothyroxine	O
TRANSITIONAL	O
ISSUES:	O
#Discharge	O
Weight	O
67.2	O
kg	O
#Lasix	O
held	O
on	O
discharge	O
as	O
she	O
remained	O
euvolemic	O
off	O
diuretics.	O
Likely	O
does	O
not	O
need	O
diuretics	O
anymore	O
given	O
AS	O
has	O
been	O
corrected	O
by	O
TAVR.	O
#INR	O
3.7	O
on	O
discharge:	O
Warfarin	O
should	O
be	O
held	O
on	O
___	O
and	O
___.	O
Please	O
check	O
INR	O
on	O
___	O
and	O
start	O
new	O
regimen	O
of	O
2mg	O
daily.	O
#Patient	O
should	O
follow	O
up	O
with	O
her	O
cardiologist	O
in	O
the	O
next	O
2	O
weeks	O
for	O
consideration	O
of	O
an	O
event	O
monitor	O
in	O
the	O
event	O
that	O
this	O
was	O
arrythmogenic	O
syncope.	O
#Metoprolol	O
XL	O
50mg	O
daily	O
decreased	O
to	O
25mg	O
daily	O
for	O
borderline	O
bradycardia.	O
#Allopurinol	O
___	O
daily	O
decreased	O
to	O
100mg	O
daily	O
for	O
chronic	O
renal	O
dysfunction.	O
#CODE:	O
FULL	O
#CONTACT:	O
___	O
(husband)	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
3.	O
Furosemide	O
60	O
mg	O
PO	O
DAILY	O
4.	O
TraZODone	O
25	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
5.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Mild	O
6.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
7.	O
Betamethasone	O
Dipro	O
0.05%	O
Cream	O
1	O
Appl	O
TP	O
BID	O
8.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
9.	O
Cyanocobalamin	O
500	O
mcg	O
PO	O
DAILY	O
10.	O
DULoxetine	O
40	O
mg	O
PO	O
DAILY	O
11.	O
Gabapentin	O
100	O
mg	O
PO	O
QHS	O
12.	O
Levothyroxine	O
Sodium	O
75	O
mcg	O
PO	O
5X/WEEK	O
(___)	O
13.	O
Levothyroxine	O
Sodium	O
112	O
mcg	O
PO	O
2X/WEEK	O
(MO,FR)	O
14.	O
melatonin	O
3	O
mg	O
oral	O
qHS	O
15.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
16.	O
Sodium	O
Chloride	O
Nasal	O
___	O
SPRY	O
NU	O
DAILY:PRN	O
dry	O
nose	O
17.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
18.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
19.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
20.	O
Pramipexole	O
0.125	O
mg	O
PO	O
DAILY	O
21.	O
Metolazone	O
2.5	O
mg	O
PO	O
ONCE	O
22.	O
Warfarin	O
2	O
mg	O
PO	O
4X/WEEK	O
(___)	O
23.	O
Warfarin	O
3	O
mg	O
PO	O
3X/WEEK	O
(___)	O
Discharge	O
Medications:	O
1.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
2.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
3.	O
Warfarin	O
2	O
mg	O
PO	O
DAILY16	O
4.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Mild	O
5.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
6.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
7.	O
Betamethasone	O
Dipro	O
0.05%	O
Cream	O
1	O
Appl	O
TP	O
BID	O
8.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
9.	O
Cyanocobalamin	O
500	O
mcg	O
PO	O
DAILY	O
10.	O
DULoxetine	O
40	O
mg	O
PO	O
DAILY	O
11.	O
Gabapentin	O
100	O
mg	O
PO	O
QHS	O
12.	O
Levothyroxine	O
Sodium	O
112	O
mcg	O
PO	O
2X/WEEK	O
(MO,FR)	O
13.	O
Levothyroxine	O
Sodium	O
75	O
mcg	O
PO	O
5X/WEEK	O
(___)	O
14.	O
melatonin	O
3	O
mg	O
oral	O
qHS	O
15.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
16.	O
Pramipexole	O
0.125	O
mg	O
PO	O
DAILY	O
17.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
18.	O
Sodium	O
Chloride	O
Nasal	O
___	O
SPRY	O
NU	O
DAILY:PRN	O
dry	O
nose	O
19.	O
TraZODone	O
25	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
20.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
Syncope	O
and	O
Fall	O
Anemia	O
Aortic	O
stenosis	O
s/p	O
TAVR	O
Atrial	O
fibrillation	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
during	O
your	O
stay	O
at	O
___	O
___.	O
During	O
your	O
stay	O
with	O
us,	O
we	O
evaluated	O
you	O
for	O
your	O
syncope	O
and	O
fall.	B-Falls
We	O
determined	O
that	O
your	O
fall	O
was	O
unlikely	O
due	O
to	O
an	O
abnormal	O
heart	O
rhythm	O
or	O
structural	O
heart	O
abnormality.	O
However,	O
you	O
should	O
follow	O
up	O
with	O
your	O
cardiologist	O
for	O
consideration	O
of	O
a	O
heart	O
monitor	O
that	O
could	O
capture	O
any	O
future	O
syncopal	O
episodes.	O
During	O
your	O
stay	O
with	O
us,	O
we	O
also	O
found	O
that	O
you	O
had	O
a	O
decreased	O
red	O
blood	O
cell	O
count.	O
We	O
performed	O
a	O
CT	O
scan	O
of	O
your	O
head,	B-Intracranial_haemorrhage
abdomen,	O
and	O
pelvis	O
which	O
showed	O
no	O
evidence	O
of	O
bleeding.	B-Intracranial_haemorrhage
We	O
gave	O
you	O
a	O
transfusion	O
of	O
2	O
units	O
of	O
red	O
blood	O
cells	O
which	O
corrected	O
your	O
hemoglobin	O
level.	O
Your	O
iron	O
levels	O
were	O
low	O
and	O
ferritin	O
level	O
(body's	O
iron	O
stores)	O
were	O
elevated,	O
indicating	O
possible	O
anemia	O
of	O
chronic	O
disease/inflammation.	O
Your	O
vitamin	O
B12	O
levels	O
were	O
elevated	O
and	O
your	O
folate	O
levels	O
were	O
normal.	O
We	O
recommend	O
having	O
ongoing	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
to	O
check	O
your	O
hemoglobin	O
levels	O
regularly.	O
If	O
you	O
experience	O
any	O
new	O
or	O
ongoing	O
falls,	B-Falls
dizziness,	O
lightheadedness,	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
nausea,	O
or	O
vomiting,	O
please	O
return	O
to	O
the	O
hospital	O
for	O
further	O
care.	O
We	O
wish	O
you	O
all	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

